Influence of disease phase on embitterment and emotional dysregulation in psoriatic patients.
Saved in:
| Title: | Influence of disease phase on embitterment and emotional dysregulation in psoriatic patients. |
|---|---|
| Authors: | Almeida, V., Constante, D., Leite, A., Almeida, I. F., Rocha, J. C., Sá, R., Teixeira, M., Teixeira, A. |
| Source: | Psychology, Health & Medicine. Feb2021, Vol. 26 Issue 2, p242-259. 18p. 6 Charts. |
| Subjects: | Adjustment disorders, Antidepressants, Anxiety, Coffee, Mental depression, Alcohol drinking, Emotion regulation, Psoriasis, Satisfaction, Self-control, Smoking, Tranquilizing drugs, Symptoms, Disease exacerbation, Family history (Medicine), Patients' attitudes |
| Abstract: | This study aimed to evaluate the psychosocial differences between patients with psoriasis in different phases of the disease. Seventy-one patients in exacerbation and 83 in remission were evaluated regarding sociodemographic, clinical and psychological variables, on the premise that the visibility of lesions (exacerbation phase) may impact the emotional regulation and embitterment. A regression analysis was performed to identify the variables that contribute to explain embitterment: a diagnosis of anxiety and/or depression and psoriasis severity are the identified ones. The results point to higher values of emotional dysregulation and embitterment, as well as more critical clinical variables in patients with active disease, namely, alcohol and coffee consumption, smoking and less satisfaction with current treatment, more diagnoses and more family history of anxiety and depression, more psychology/psychiatry consultations and more use of anxiolytics and antidepressants. However, only the results referring to alcohol consumption and embitterment are significantly higher in subjects in the exacerbation phase of the disease. Particular clinical attention should be provided to patients in exacerbation phase regarding psychotherapeutic approach. [ABSTRACT FROM AUTHOR] |
| Copyright of Psychology, Health & Medicine is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | This study aimed to evaluate the psychosocial differences between patients with psoriasis in different phases of the disease. Seventy-one patients in exacerbation and 83 in remission were evaluated regarding sociodemographic, clinical and psychological variables, on the premise that the visibility of lesions (exacerbation phase) may impact the emotional regulation and embitterment. A regression analysis was performed to identify the variables that contribute to explain embitterment: a diagnosis of anxiety and/or depression and psoriasis severity are the identified ones. The results point to higher values of emotional dysregulation and embitterment, as well as more critical clinical variables in patients with active disease, namely, alcohol and coffee consumption, smoking and less satisfaction with current treatment, more diagnoses and more family history of anxiety and depression, more psychology/psychiatry consultations and more use of anxiolytics and antidepressants. However, only the results referring to alcohol consumption and embitterment are significantly higher in subjects in the exacerbation phase of the disease. Particular clinical attention should be provided to patients in exacerbation phase regarding psychotherapeutic approach. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 13548506 |
| DOI: | 10.1080/13548506.2020.1741655 |
